Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2017 (← Previous) (Next →)

Filing Date: Nov 3, 2017

Total Value ($000): $176,759 (100.0% shares, 0.0% debt)

Holdings (11)

— Paratek Pharmaceuticals 36.9%

Value ($000) $65,270 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Juno Therapeutics 27.3%

Value ($000) $48,207 Shares 1,074,612 Est. Cost $52.22 Unrealized —

— FibroGen 9.6%

Value ($000) $16,912 Shares 314,348 Est. Cost $27.34 Unrealized —

SNNAQ Sienna Biopharmaceuticals 9.5%

Value ($000) $16,879 Shares 758,610 Est. Cost $21.95 Unrealized 0.0%

— Jounce Therapeutics 5.1%

Value ($000) $9,031 Shares 579,650 Est. Cost $21.99 Unrealized —

— Pieris Pharmaceuticals 3.9%

Value ($000) $6,935 Shares 1,204,053 Est. Cost $1.83 Unrealized —

— CymaBay Therapeutics 2.5%

Value ($000) $4,445 Shares 551,477 Est. Cost $4.71 Unrealized —

— Egalet 2.1%

Value ($000) $3,699 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— Cidara Therapeutics 2.0%

Value ($000) $3,604 Shares 444,965 Est. Cost $10.40 Unrealized —

— Dicerna Pharmaceuticals 0.7%

Value ($000) $1,285 Shares 223,457 Est. Cost $16.47 Unrealized —

— ESSA Pharma 0.3%

Value ($000) $492 Shares 1,696,969 Est. Cost $5.22 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Paratek Pharmaceuticals	2,600,410	$65,270	36.9%	$34.18	—	Common Stock	699374302
—	Juno Therapeutics	1,074,612	$48,207	27.3%	$52.22	—	Common Stock	48205A109
—	FibroGen	314,348	$16,912	9.6%	$27.34	—	Common Stock	31572Q808
SNNAQ	Sienna Biopharmaceuticals	758,610	$16,879	9.5%	$21.95	0.0%	Common Stock	82622H108
—	Jounce Therapeutics	579,650	$9,031	5.1%	$21.99	—	Common Stock	481116101
—	Pieris Pharmaceuticals	1,204,053	$6,935	3.9%	$1.83	—	Common Stock	720795103
—	CymaBay Therapeutics	551,477	$4,445	2.5%	$4.71	—	Common Stock	23257D103
—	Egalet	2,889,926	$3,699	2.1%	$5.98	—	Common Stock	28226B104
—	Cidara Therapeutics	444,965	$3,604	2.0%	$10.40	—	Common Stock	171757107
—	Dicerna Pharmaceuticals	223,457	$1,285	0.7%	$16.47	—	Common Stock	253031108
—	ESSA Pharma	1,696,969	$492	0.3%	$5.22	—	Common Stock	29668H104